PRESENTATION

Q1 FY2023 — Presentation

Q1 FY2023PDF · 18 pages795 KB
CACI Proprietary Information
CACI International Inc
Q1 FY23 Earnings Conference Call
October 27, 2022
CACI Proprietary Information

-- 1 of 18 --

2 | CACI Proprietary Information CACI Q1 FY23 Earnings Conference Call
There are statements made herein that do not address historical facts and, therefore, could be interpreted to be forward-
looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are subject
to risk factors that could cause actual results to be materially different from anticipated results. These risk factors include, but
are not limited to, the following: our reliance on U.S. government contracts, which includes general risk around the government
contract procurement process (such as bid protest, small business set asides, loss of work due to organizational conflicts of
interest, etc.) and termination risks; significant delays or reductions in appropriations for our programs and broader changes in
U.S. government funding and spending patterns; legislation that amends or changes discretionary spending levels or budget
priorities, such as for homeland security or to address global pandemics like COVID-19; legal, regulatory, and political change
from successive presidential administrations that could result in economic uncertainty; changes in U.S. federal agencies, current
agreements with other nations, foreign events, or any other events which may affect the global economy, including the impact
of global pandemics like COVID-19; the results of government audits and reviews conducted by the Defense Contract Audit
Agency, the Defense Contract Management Agency, or other governmental entities with cognizant oversight; competitive
factors such as pricing pressures and/or competition to hire and retain employees (particularly those with security clearances);
failure to achieve contract awards in connection with re-competes for present business and/or competition for new business;
regional and national economic conditions in the United States and globally, including but not limited to: terrorist activities or
war, changes in interest rates, currency fluctuations, significant fluctuations in the equity markets, and market speculation
regarding our continued independence; our ability to meet contractual performance obligations, including technologically
complex obligations dependent on factors not wholly within our control; limited access to certain facilities required for us to
perform our work, including during a global pandemic like COVID-19; changes in tax law, the interpretation of associated rules
and regulations, or any other events impacting our effective tax rate; changes in technology; the potential impact of the
announcement or consummation of a proposed transaction and our ability to successfully integrate the operations of our
recent and any future acquisitions; our ability to achieve the objectives of near term or long-term business plans; the effects of
health epidemics, pandemics and similar outbreaks may have material adverse effects on our business, financial position, results
of operations and/or cash flows; and other risks described in our Securities and Exchange Commission filings.
Forward-looking Statements

-- 2 of 18 --

3 | CACI Proprietary Information CACI Q1 FY23 Earnings Conference Call
On Today’s Call
John Mengucci
President and Chief
Executive Officer
Thomas Mutryn
Chief Financial Officer
Jeffrey MacLauchlan
Senior Vice President
of Finance

-- 3 of 18 --

4 | CACI Proprietary Information CACI Q1 FY23 Earnings Conference Call
Revenue +8%, organic growth +4%
Adjusted EBITDA Margin 10.6%1
Strong free cash flow of $130 million1
Contract awards of $3.2 billion, >80% new business to CACI
Q1 book-to-bill of 2.0x, trailing twelve months (TTM) book-to-bill 1.3x
Q1 FY23 Financial Highlights
1 See slides at the end of this presentation for definitions and reconciliations of non-GAAP measures.

-- 4 of 18 --

5 | CACI Proprietary Information CACI Q1 FY23 Earnings Conference Call
Market demand remains strong
Continued bipartisan support for national security and modernization
CR through December 16th but GFY23 budget seeing increases as it moves
through Congress
Higher spending in Defense, Intelligence, and Homeland Security
Higher spending in key addressable areas including Digital Solutions, Enterprise IT, and
C4ISR, Cyber, and Space
Confident in our ability to drive long-term growth, margin expansion, robust
cash flow, and shareholder value
External Environment

-- 5 of 18 --

6 | CACI Proprietary Information CACI Q1 FY23 Earnings Conference Call
Space
Investing in photonics capabilities gained through LGS and SA Photonics acquisitions
Focused on multi-year, technology-driven growth opportunities in Assured Positioning
Navigation and Timing (APNT) and Laser Remote Sensing (or LiDAR)
C4ISR
CACI providing advanced, classified technology to the U.S. Space Force
Investments in software-defined capabilities differentiating CACI in the market
Enterprise IT
Leveraging partnerships with commercial technology providers (e.g., AWS, ServiceNow)
Won $5.7 billion Enterprise IT as-a-Service (EITaaS) Wave 1 from U.S. Air Force
(approximately $2 billion included in Q1 FY23 contract awards and backlog)
Technology enabling Expertise
Leveraging technology investments to engage customers and differentiate CACI Expertise
Investing Ahead of Need

-- 6 of 18 --

7 | CACI Proprietary Information CACI Q1 FY23 Earnings Conference Call
Q1 Financial Summary
$1,491
$1,606
$1,200
$1,300
$1,400
$1,500
$1,600
$1,700
Q1 FY22 Q1 FY23
Revenue (Ms)
Organic revenue growth +4.3%, driven by
new wins and on-contract growth
Technology revenue +10.6%
Adjusted EBITDA Margin of 10.6%1
GAAP EPS and Adjusted EPS up YoY on
higher revenue and gross profit, and
despite higher interest expense
+7.7%
1 See slides at the end of this presentation for definitions and reconciliations of non-GAAP measures.
$4.24 $4.36
$0.00
$1.00
$2.00
$3.00
$4.00
$5.00
$6.00
Q1 FY22 Q1 FY23
Adjusted EPS1
+2.8%
$3.70 $3.76
$0.00
$1.00
$2.00
$3.00
$4.00
$5.00
Q1 FY22 Q1 FY23
EPS (GAAP)
+1.6%

-- 7 of 18 --

8 | CACI Proprietary Information CACI Q1 FY23 Earnings Conference Call
Strong Cash Flow
$0
$100
$200
$300
$400
$500
$600
$700
$800
Cash Flow1 and CapEx
(millions, TTM)
Cash Flow from Operations excl. MARPA Capital Expenditures (CapEx)
1
$0.00
$5.00
$10.00
$15.00
$20.00
$25.00
$30.00
$35.00
FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23E
Free Cash Flow (FCF) per Share1,2
1 Excludes CACI’s Master Accounts Receivable Purchase Agreement (MARPA). FY20 includes CARES Act payroll tax
deferral benefit of ~$41 million. FY21 includes CARES Act payroll tax deferral benefit of ~$53 million and tax
payment of ~$90 million related to certain tax elections. FY22 includes tax benefits of ~$190 million related to
certain tax elections and repayment of payroll tax deferral of ~$47 million. FY23E includes estimated net tax
payments of ~$25 million related to certain tax elections and repayment of payroll tax deferral of ~$47 million.
See slides at the end of this presentation for definitions and reconciliations of non-GAAP measures.
FY23E is based on guidance provided on October 26, 2022. Investors
are reminded that actual results may differ from these estimates for reasons
described in the Company’s Safe Harbor Statement and filings with the SEC.
FY14 to FY19 FY15 to FY20 FY16 to FY21 FY17 to FY22 FY18 to FY23E
5-Year CAGR 10.6% 14.9% 19.2% 25.3% 9.5%
2 Assumes Section 174 of the Tax Cuts and Jobs Act of 2017 will be deferred, modified
or repealed. CACI currently estimates that, if not deferred, modified or repealed,
FY23 operating cash flow would be reduced by approximately $95 million.

-- 8 of 18 --

9 | CACI Proprietary Information CACI Q1 FY23 Earnings Conference Call
Reaffirming FY23 Guidance
FY23 Guidance
Revenue
(millions) $6,475 – $6,675
Adjusted Net Income1
(millions) $420 – $440
Adjusted Diluted EPS1 $17.65 – $18.49
Free Cash Flow1,2
(millions) At least $415
This guidance represents CACI views as of October 26, 2022. Investors are
reminded that actual results may differ from these estimates for reasons
described in the Company’s Safe Harbor Statement and filings with the SEC.
Revenue growth of ~4.5% to ~7.5%
Inorganic revenue of ~$180 million
or ~3 points of growth
Adjusted EBITDA Margin1 in the
mid-to-high 10% range
Interest expense of ~$75 million
Diluted shares outstanding expected
to be ~23.8 million
Capital expenditures of
~$80 million
1 See slides at the end of this presentation for definitions and reconciliations of non-GAAP measures.
2 Assumes Section 174 of the Tax Cuts and Jobs Act of 2017 will be deferred, modified or repealed.
CACI currently estimates that, if not deferred, modified or repealed, FY23 operating cash flow would
be reduced by approximately $95 million.

-- 9 of 18 --

10 | CACI Proprietary Information CACI Q1 FY23 Earnings Conference Call
Positive Forward Indicators
90%
Existing Business
STRONG
Performance
5%
Recompetes
HIGH
Win Rate
5%
New Business
QUALITY
Pipeline
Strong Q1 FY23 contract awards of
$3.2 billion
TTM Book-to-Bill of 1.3x
Backlog of $24.9 billion, +4% YoY
Pipeline of submitted bids: $10.8 billion
>70% for new business to CACI
Bids expected to be submitted in the
next two quarters: $16.3 billion
>90% for new business to CACI

-- 10 of 18 --

11 | CACI Proprietary Information CACI Q1 FY23 Earnings Conference Call
We delivered strong revenue growth, margins, and cash flow in Q1
Strong awards, growing backlog, and robust pipeline of opportunities
Focused on long-term growth, margin expansion, robust cash flow, and free cash flow
per share growth
Successfully investing ahead of need to drive growth and differentiation
Flexible and opportunistic capital deployment to deliver long-term shareholder value
Talented, innovative, committed employees driving customer and CACI success
Great Start to FY23

-- 11 of 18 --

12 | CACI Proprietary Information CACI Q1 FY23 Earnings Conference Call
Appendix

-- 12 of 18 --

13 | CACI Proprietary Information CACI Q1 FY23 Earnings Conference Call
FY23 Cash Flow
Ms
FY22 Cash from Operations excl. MARPA 1 $770
Method change in FY22 ($190)
Method change delayed from FY22 $40
Method change impact in FY23 ($65)
Working capital and other ($60)
FY23 Cash from Operations excl. MARPA 1,2 $495
FY23 Capital expenditures $80
FY23 Free Cash Flow 1,2 $415
FY22
Cash from
Operations
excl.
MARPA1
Method
change in
FY22
Method
change
delayed
from FY22
Method
change
impact in
FY23
Working
capital and
other
FY23
Cash from
Operations
excl.
MARPA1,2
1 See slides at the end of this presentation for definitions and reconciliations
of non-GAAP measures.
2 Assumes Section 174 of the Tax Cuts and Jobs Act of 2017 will be deferred,
modified or repealed. CACI currently estimates that, if not deferred,
modified or repealed, FY23 operating cash flow would be reduced by
approximately $95 million.
This guidance represents CACI views as of October 26, 2022. Investors are
reminded that actual results may differ from these estimates for reasons
described in the Company’s Safe Harbor Statement and filings with the SEC.

-- 13 of 18 --

14 | CACI Proprietary Information CACI Q1 FY23 Earnings Conference Call
Adjusted net income and Adjusted diluted EPS are non-GAAP performance measures. We define Adjusted net income and Adjusted diluted EPS as GAAP net
income and GAAP diluted EPS, respectively, excluding intangible amortization expense and the related tax impact as we do not consider intangible amortization
expense to be indicative of our core operating performance. We believe that these performance measures provide management and investors with useful
information in assessing trends in our ongoing operating performance, provide greater visibility in understanding the long-term financial performance of the
Company, and allow investors to more easily compare our results to results of our peers.
The Company views Adjusted EBITDA and Adjusted EBITDA margin, both of which are defined as non-GAAP measures, as important indicators of performance,
consistent with the manner in which management measures and forecasts the Company’s performance. Adjusted EBITDA is a commonly used non-GAAP
measure when comparing our results with those of other companies. We define Adjusted EBITDA as GAAP net income plus net interest expense, income taxes,
depreciation and amortization expense (including depreciation within direct costs), and earnout adjustments. We consider Adjusted EBITDA to be a useful metric
for management and investors to evaluate and compare the ongoing operating performance of our business on a consistent basis across reporting periods, as it
eliminates the effect of non-cash items such as depreciation of tangible assets, amortization of intangible assets primarily recognized in business combinations,
as well as the effect of earnout gains and losses, which we do not believe are indicative of our core operating performance. Adjusted EBITDA margin is Adjusted
EBITDA divided by revenue. A reconciliation of Adjusted EBITDA Margin to the closest corresponding GAAP measure is not available without unreasonable efforts
on a forward-looking basis due to our inability to predict specific quantifications of the amounts that would be required to reconcile such measures.
Consequently, any attempt to disclose such reconciliation would imply a degree of precision that could be confusing or misleading to investors.
The Company defines Net cash provided by operating activities excluding MARPA, a non-GAAP measure, as net cash provided by operating activities calculated
in accordance with GAAP, adjusted to exclude cash flows from CACI’s Master Accounts Receivable Purchase Agreement (MARPA) for the sale of certain
designated eligible U.S. government receivables up to a maximum amount of $200.0 million. Free cash flow is a non-GAAP liquidity measure and may not be
comparable to similarly titled measures used by other companies. The Company defines Free cash flow as Net cash provided by operating activities excluding
MARPA, less payments for capital expenditures. The Company uses these non-GAAP measures to assess our ability to generate cash from our business
operations and plan for future operating and capital actions. We believe these measures allow investors to more easily compare current period results to prior
period results and to results of our peers. Free cash flow does not represent residual cash flows available for discretionary purposes and should not be used as a
substitute for cash flow measures prepared in accordance with GAAP.
These non-GAAP measures should not be considered in isolation or as a substitute for financial measures prepared in accordance with GAAP.
Definitions of Non-GAAP Measures

-- 14 of 18 --

15 | CACI Proprietary Information CACI Q1 FY23 Earnings Conference Call
Reconciliation of Net Income to Adjusted Net Income and
Diluted EPS to Adjusted Diluted EPS (Unaudited)
These non-GAAP measures should not be considered in isolation or as a substitute for financial measures prepared in accordance with GAAP.
(in thousands, except per share data)
9/30/2022 9/30/2021 % Change
Net income, as reported 	89,125	$ 	88,109	$ 	1.2%
Intangible amortization expense 	19,114 17,593 8.6%
Tax effect of intangible amortization1
(4,950) (4,626) 7.0%
Adjusted net income 	103,289	$ 	101,076	$ 	2.2%
9/30/2022 9/30/2021 % Change
Diluted EPS, as reported 	3.76	$ 	3.70	$ 	1.6%
Intangible amortization expense 	0.81 0.74 9.5%
Tax effect of intangible amortization1 (0.21) (0.20) 5.0%
Adjusted diluted EPS 	4.36	$ 	4.24	$ 	2.8%
(in millions, except per share data)
Low End 	High End
Net income, as reported 	364	$ 	--- 	384	$
Intangible amortization expense 	75 --- 	75
Tax effect of intangible amortization1
(19) --- 	(19)
Adjusted net income 	420	$ 	--- 	440	$
Low End 	High End
Diluted EPS, as reported 	15.29	$ 	--- 	16.13	$
Intangible amortization expense 	3.15 --- 	3.15
Tax effect of intangible amortization1
(0.80) --- 	(0.80)
Adjusted diluted EPS 	17.65	$ 	--- 	18.49	$
FY23 Guidance Range
FY23 Guidance Range
(1) Calculation uses an assumed full year statutory tax rate of 25.9% and 26.3% on non-
GAAP tax deductible adjustments for September 30, 2022 and 2021, respectively.
Three Months Ended
Three Months Ended

-- 15 of 18 --

16 | CACI Proprietary Information CACI Q1 FY23 Earnings Conference Call
Reconciliation of Net Income to Adjusted Earnings Before Interest,
Taxes, Depreciation and Amortization (Adjusted EBITDA) (Unaudited)
These non-GAAP measures should not be considered in isolation or as a substitute for financial measures prepared in accordance with GAAP.
(in thousands) 	9/30/2022 9/30/2021 % Change
Net income 	89,125	$ 	88,109	$ 	1.2%
Plus:
Income taxes 	27,485 	28,522 -3.6%
Interest income and expense, net 	16,193 	10,398 55.7%
Depreciation and amortization expense,
including amounts within direct costs 37,231 	33,911 	9.8%
Adjusted EBITDA 	170,034	$ 	160,940	$ 	5.7%
(in thousands) 	9/30/2022 9/30/2021 % Change
Revenues, as reported 	1,605,759	$ 	1,490,898	$ 	7.7%
Adjusted EBITDA 	170,034 	160,940 	5.7%
Adjusted EBITDA margin 	10.6% 	10.8%
Three Months Ended
Three Months Ended

-- 16 of 18 --

17 | CACI Proprietary Information CACI Q1 FY23 Earnings Conference Call
Reconciliation of Net Cash Provided by Operating Activities to Net
Cash Provided by Operating Activities Excluding MARPA and to Free
Cash Flow (Unaudited)
These non-GAAP measures should not be considered in isolation or as a substitute for financial measures prepared in accordance with GAAP.
(in thousands) 	9/30/2022 9/30/2021
Net cash provided by operating activities 	144,843	$ 	185,953	$
Cash used in (provided by) MARPA 	(1,904) 	(11,489)
Net cash provided by operating activities excluding MARPA 	142,939 	174,464
Capital expenditures 	(12,771) 	(10,203)
Free cash flow 	130,168	$ 	164,261	$
(in millions) 	FY23 Guidance
Net cash provided by operating activities 	495	$
Cash used in (provided by) MARPA 	-
Net cash provided by operating activities excluding MARPA 	495
Capital expenditures 	(80)
Free cash flow 	415	$
Three Months Ended

-- 17 of 18 --

18 | CACI Proprietary Information CACI Q1 FY23 Earnings Conference Call
Reconciliation of Net Cash Provided by Operating Activities to Net
Cash Provided by Operating Activities Excluding MARPA, to Free
Cash Flow, and to Free Cash Flow per share (Unaudited)
These non-GAAP measures should not be considered in isolation or as a substitute for financial measures prepared in accordance with GAAP.
(in thousands, except per share data) 6/30/2014 6/30/2015 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 (E)
Net cash provided by operating activities 203,470	$ 226,862	$ 242,577	$ 281,250	$ 321,460	$ 555,297	$ 518,705	$ 592,215	$ 745,554	$ 495,000	$
Cash used in (provided by) MARPA - - - - - (192,527) (7,473) 17,973 24,242 -
Net cash provided by operating activities excluding MARPA1 203,470 226,862 242,577 281,250 321,460 362,770 511,232 610,188 769,796 495,000
Capital expenditures (15,279) (17,444) (20,835) (43,268) (41,594) (47,902) (72,303) (73,129) (74,564) (80,000)
Free cash flow 188,191	$ 209,418	$ 221,742	$ 237,982	$ 279,866	$ 314,868	$ 438,929	$ 537,059	$ 695,232	$ 415,000	$
Diluted weighted average shares outstanding 25,155 24,388 24,802 25,069 25,255 25,395 25,485 24,992 23,677 23,800
Free cash flow per share 7.48	$ 8.59	$ 8.94	$ 9.49	$ 11.08	$ 12.40	$ 17.22	$ 21.49	$ 29.36	$ 17.44	$
5-Year CAGR 10.6% 14.9% 19.2% 25.3% 9.5%
Twelve Months Ended
1 Excludes CACI’s Master Accounts Receivable Purchase Agreement (MARPA). FY20 includes CARES Act payroll tax deferral benefit of ~$41 million. FY21 includes CARES Act payroll tax deferral benefit of ~$53
million and tax payment of ~$90 million due to certain tax elections. FY22 includes tax benefits of ~$190 million and repayment of payroll tax deferral of ~$47 million. FY23E includes estimated net tax payments
of ~$25 million and repayment of payroll tax deferral of ~$47 million.
Note: 6/30/2023 (E) reflects estimate for fiscal year 2023 based on financial guidance provided. 6/30/2023 (E) also assumes Section 174 of the Tax Cuts and Jobs Act of 2017 will be deferred, modified or
repealed. CACI currently estimates that, if not deferred, modified or repealed, FY23 operating cash flow would be reduced by approximately $95 million.

-- 18 of 18 --